Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Intercure Ltd. files with the SEC in its annual reports.
In ILS millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2019
FY2021
FY2021
FY2022
FY2023
FY2024
Revenue
8.93
65
220
389
356
239
Cost of revenue
7.46
34.6
124
230
247
203
Gross profit
1.48
32
91.1
155
105
30.2
Research and development
1.71
1.58
1.24
0.63
0.39
0.41
Operating income
-3.42
-38.4
28.2
50.6
-41.6
-67.2
Interest income
0.14
0.62
0.13
8.17
5.88
2.75
Pre-tax income
-6.57
-38.3
18.7
43.8
-61.3
-87.3
Income tax
-0.67
-2.27
11.4
0.09
2.25
-14.5
Net income to minority interests
1.19
2.6
-1.07
-1.57
-5
Net income
-5.89
-37.2
4.69
44.8
-62
-67.8
EPS, basic
-0.25
-1.42
0.12
0.99
-1.36
-1.48
EPS, diluted
-0.25
-1.42
0.11
0.99
-1.36
-1.48
Balance sheet
FY2019
FY2021
FY2021
FY2022
FY2023
FY2024
Cash and equivalents
27.3
37.9
196
233
101
78.3
Short-term investments
0.33
0.16
0.19
0.33
Inventory
19
62.3
140
105
120
Total current assets
76.7
336
527
419
392
Property, plant and equipment
53.5
86.5
103
97.5
105
Goodwill
190
268
284
221
225
Total assets
282
326
697
958
787
763
Short-term debt
0.36
70.6
127
88.2
69.4
Total current liabilities
29.9
194
313
226
227
Lease liabilities
3.5
21.4
23.1
20.6
23.2
Total liabilities
-26
34.2
227
437
330
365
Total debt
227
170
183
Retained earnings
-191
-186
-142
-204
-278
Shareholders' equity
275
448
501
455
397
Minority interests
17.6
21.4
20.2
1.95
0.7
Total equity
256
292
469
521
457
398
Total liabilities and equity
230
326
697
958
787
763
Cash flow statement
FY2019
FY2021
FY2021
FY2022
FY2023
FY2024
Net income
-5.89
-36
7.29
43.7
-63.5
-72.8
Cash from operations
-11.6
7.9
30.1
51.3
-53.6
-66.9
Capital expenditures
-28.1
-20.8
-14
-19.7
-2.62
-4.38
Cash from investing
-26.1
-22.8
-65.2
-142
4.77
17.7
Debt issued
0.67
75.5
263
62.7
188
Debt repaid
-0.17
-3.42
-121
-120
-175
Cash from financing
63.2
25.2
198
120
-82.9
26.5
Exchange rate effect
-1.66
0.22
-4.54
7.16
0.3
-0.04
Free cash flow
-39.7
-12.9
16.1
31.5
-56.3
-71.3
Interest paid
0.04
0.09
5.12
Income taxes paid
0.05
11.8
7.97
7.61
12.9
Key metrics
Worked out from the statements above. Latest values use fiscal 2024. No valuation: the share price is quoted in a different currency than the statements.
Profitability
Metric
Value
How it is calculated
Gross margin
12.7%
Gross profit / revenue.
Operating margin
-28.1%
Operating income / revenue.
Pre-tax margin
-36.6%
Pre-tax income / revenue.
Net margin
-28.4%
Net income / revenue.
FCF margin
-29.9%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-28.0%
Cash from operations / revenue.
Return on equity (ROE)
-15.9%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-8.8%
Net income / average total assets.
Return on invested capital (ROIC)
-10.4%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
0.2%
Research and development expense / revenue.
Capex / revenue
1.8%
Capital expenditures / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-32.8%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
2.8%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
93.0%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-71.2%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-30.8%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
82.9%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-12.8%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-4.0%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
-3.1%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
3.1%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
22.0%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.73x
Current assets / current liabilities.
Quick ratio
0.35x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.35x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.46x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
24.0%
Total debt / total assets.
Liabilities / assets
47.9%
Total liabilities / total assets.
Net debt
₪104.3M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-₪1.48
Net income per basic share, as reported (split-adjusted).
What was Intercure Ltd.'s revenue in fiscal 2024?
Intercure Ltd. reported revenue of ₪238.8M for fiscal 2024, 32.8% lower than the year before.
Was Intercure Ltd. profitable in fiscal 2024?
No. It reported a net loss of ₪67.8M.
How much free cash flow did Intercure Ltd. generate in fiscal 2024?
Cash from operations of ₪66.9M minus capital expenditures of ₪4.4M left free cash flow of -₪71.3M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.